Detalhe da pesquisa
1.
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
N Engl J Med
; 387(21): 1957-1968, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346079
2.
Analysis of C. difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials.
Eur J Clin Microbiol Infect Dis
; 39(10): 1933-1939, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504314
3.
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.
J Viral Hepat
; 26(9): 1040-1049, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972912
4.
Epidemiological investigation on hepatitis A virus infection outbreak in the area of Rzeszow city during the years 2017/18.
Clin Exp Hepatol
; 6(4): 321-326, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33511279
5.
Prevalence of hepatitis delta infections among HBs-antigen-positive inhabitants of southeastern and northwestern parts of Poland.
Clin Exp Hepatol
; 5(3): 232-236, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31598560
6.
Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.
Adv Med Sci
; 62(2): 387-392, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28554119
7.
Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study.
Clin Exp Hepatol
; 2(4): 138-143, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28856278
8.
Prevalence of HCV genotypes in Poland - the EpiTer study.
Clin Exp Hepatol
; 2(4): 144-148, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28856279